Societal Cdmo Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SOCIETAL CDMO, and what generic and branded alternatives to SOCIETAL CDMO drugs are available?
SOCIETAL CDMO has two approved drugs.
Drugs and US Patents for Societal Cdmo
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Societal Cdmo | VERELAN PM | verapamil hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 020943-001 | Nov 25, 1998 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Societal Cdmo | VERELAN | verapamil hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 019614-004 | May 10, 1996 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Societal Cdmo | VERELAN PM | verapamil hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 020943-002 | Nov 25, 1998 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Societal Cdmo
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Societal Cdmo | VERELAN PM | verapamil hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 020943-003 | Nov 25, 1998 | 4,863,742 | ⤷ Try a Trial |
Societal Cdmo | VERELAN | verapamil hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 019614-002 | May 29, 1990 | 4,863,742 | ⤷ Try a Trial |
Societal Cdmo | VERELAN | verapamil hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 019614-004 | May 10, 1996 | 4,863,742 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for SOCIETAL CDMO drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Extended-release Tablets | 100 mg and 200 mg | ➤ Subscribe | 2006-07-20 |
➤ Subscribe | Extended-release Tablets | 300 mg | ➤ Subscribe | 2006-05-19 |
Similar Applicant Names
Here is a list of applicants with similar names.